ASX Announcements

Neuren initiates manufacture of NNZ-2591 for Phase 2 trials
Half-year Shareholder Update
Half Yearly Report and Accounts
Corporate presentation, 18 August 2020
Change of Director's Interest Notice
Appendix 2A
Change of Director's Interest Notice
Completion of Share Purchase Plan
Appointment of CFO & Company Secretary
Q2 2020 Activity Report and Cash Flow Report